Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has informed the exchanges that its Board of Directors will meet on Wednesday, October 15, 2025, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025. This is a routine regulatory filing under SEBI's Listing Regulations. The company's trading window for insiders has been closed from October 1, 2025 and will remain so until 48 hours after the results are announced. No actual financial numbers have been disclosed in this notice.
This is a standard procedural filing and does not directly move the stock. The closed trading window signals that results are imminent, and investors should watch for the Q2/H1 FY26 numbers on or after October 15 for actual performance cues.